Onconova Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Onconova Therapeutics (NASDAQ:ONTX) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-0.29. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has reacted negatively to past earnings reports, even when beating EPS estimates. Shares are currently trading at $0.64, down 22.3% over the last 52 weeks, indicating general dissatisfaction among long-term shareholders.
November 13, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Onconova Therapeutics is expected to report an EPS of $-0.29 for the latest quarter. Past earnings have seen negative stock reactions, and shares are down 22.3% over the past year.
Given the historical negative reaction to earnings reports, even when beating estimates, and the current downward trend in stock price, it is likely that ONTX may experience a short-term decline in share price following the earnings announcement, especially if the company fails to meet or exceed expectations or provides weak guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100